All the News in one place from Singapore
More than 50 news sites, more than 1000 pieces of news daily
Amgen will buy a blockbuster psoriasis drug for $13.4 billion — and it’s part of a plan to get Celgene’s mega-merger with Bristol-Myers Squibb approved
(August 26 21:45) Businessinsider.sg
Celgene agreed to a $74 billion merger with Bristol-Myers Squibb back in January 2019, and it's still awaiting regulatory approval.
Share Amgen will buy a blockbuster psoriasis drug for $13.4 billion — and it’s part of a plan to get Celgene’s mega-merger with Bristol-Myers Squibb approved on your favourite social media